Humacyte’s Sabrina Osborne, Vice President of Human Resources, was named a 2019 winner for Diversity Journal’s women Worth Watching list.
Humacyte recognized for best late-stage product development company’ category.
Humacyte President and Chief Executive Officer was selected to Triangle Business Journal’s 2018 Innovation Awards List.
Humacyte was recognized for securing a $150M strategic investment from Fresenius Medical, the world’s largest dialysis company, to commercialize HUMACYL for dialysis applications.
Humacyte Chief Regulatory Office Bill Tente was selected to Triangle Business Journal’s 2018 C-Suite List.
Gretchen Smith, Humacyte’s Executive Director, Manufacturing was named a 2018 winner for Diversity Journal’s Women Worth Watching list.
Dr. Dahl was recognized by PharmaVoice for
breaking bioengineering ground,
with regenerative medicine.
Humacyte’s Theodore Lithgow, Chief Operations Officer, was recognized in the 2017 Best in Biz awards under the Executive of the Year
Medical Design & Outsourcing: Humacyte’s Carrie Cox named to 9 Women Medtech Leaders You Need to Know list
Dr. Niklason was recognized by PharmaVoice for her
contributions to the advancement of regenerative medicine,
in creating investigational human acellular vessels.
Dr. Niklason was inducted into the Women in Technology
Fall of Fame for her groundbreaking research in
regenerative
strategies for cardiovascular and lung tissues.
Senior Vice President, Product Development Dr. Heather
Prichard was named as a 2017 award winner for Diversity
Journal’s Women Worth Watching in STEM in recognition of
her work to develop technologies for improving medical
treatment for a variety of diseases.
Humacyte was selected as a 2017 Technology Pioneer by
the World Economic Forum for the potential to significantly
impact business and society through new technologies
in regenerative medicine.
Dr. Juliana Blum, Co-Founder and Vice-President, Business
Operations & Tissue Services and Jenny Jackson, Associate
Director of Reimbursement for Humacyte, were recognized to
Diversity Journal’s Women Worth Watching in 2017 award for
their personal and professional contributions to advancing
gender diversity.
Humacyte Founder, Dr. Niklason and Humacyte CEO,
Carrie Cox were both recognized to Becker’s Hospital
Review, “110 Women in Medtech to Know”
Dr. Niklason was recognized to Fortune Magazine’s prestigious
List of Leaders Transforming Health and Medicine, for her
contributions to the advancement of regenerative medicine,
in creating investigational human acellular vessels.
Dr. Laura Niklason received a LAS Alumni Achievement
Award from the University of Illinois College of Liberal
Arts & Sciences for groundbreaking work in tissue
engineering in 2016.
Humacyte was named to Fierce Innovation’s Awards Life
Sciences Edition in 2016 for creating HUMACYL
Humacyte was named to FierceBiotech’s Top 15 Private
Companies in Medical Devices for the potential to significantly
impact business and society through new technologies
in regenerative medicine.
Humacyte was highlighted as a potential breakthrough
for patients undergoing hemodialysis.
Humacyte was named to CNBC’s prestigious Disrupt 50
List for the progress HUMACYL has made since
Humacyte’s founding.
Humacyte’s Chief Medical Officer, Dr. Jeffery H. Lawson
was elected as a Fellow to the prominent American Surgical
Association for his experience and leadership as a
medical professional.
Laura Niklason, M.D., Ph.D., a world leader in tissue
engineering and cellular therapies and Founder of Humacyte,
has been elected to the prestigious National Academy of
Medicine (NAM). NAM is an independent organization of
eminent professionals from diverse fields including health
and medicine; the natural, social, and behavioral sciences,
and beyond.
Humacyte, an innovator in biotechnology and regenerative
medicine, announced today that the Company has been awarded
the 2015 North Carolina Excellence Award by the US Commerce
& Trade Research Institute (USCTRI), a leading research
authority that evaluates and recognizes businesses and
organizations that have made a significant contribution
in enterprise and entrepreneurial growth.
The Small Business Institute for Excellence in Commerce
(SBIEC) recognizes Humacyte with the 2013 North Carolina
Excellence Award for continued advancement of business
leadership and high regard for upholding business ethics
and company values among its peers.
Fierce Biotech names Carrie Cox as one of the
“Top 10 Women in Biotech”
Fast Company names Humacyte as one of the “Top 50
World’s Most Innovative Companies”
Popular Mechanics recognizes Humacyte investigational
bioengineered blood vessel technology as a “Breakthrough
Innovation of 2011.” This technology is under clinical
study by Humacyte, and Humacyte plans to seek FDA
approval of the technology.
Humacyte receives Frost & Sullivan Award for New
Product Innovation
